Anhui Province Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu 241002, PR China; Department of Biochemistry and Molecular Biology, Wannan Medical College, Wuhu 241002, PR China.
Anhui Province Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu 241002, PR China.
Gene. 2024 Oct 20;925:148591. doi: 10.1016/j.gene.2024.148591. Epub 2024 May 22.
Primary liver cancer has consistently exhibited a high prevalence and fatality rate, necessitating the investigation of associated diagnostic markers and inhibition mechanisms to effectively mitigate its impact. The significance of apolipoprotein M (ApoM) in impeding the progression of neoplastic ailments is progressively gaining recognition. However, a comprehensive understanding of its underlying mechanism in liver cancer advancement remains to be elucidated. Recent evidence indicates a potential association between ApoM and polyunsaturated fatty acids (PUFAs), with the peroxidation of phospholipids (PLs) containing PUFAs being recognized as a crucial element in the occurrence of ferroptosis. This prompts us to investigate the impact of the APOM gene on the progression of liver cancer through the ferroptosis pathway and elucidate its underlying mechanisms. The findings of this study indicate that the liver cancer cell model, which was genetically modified to overexpress the APOM gene, demonstrated a heightened ferroptosis effect. Moreover, the observed inhibition of the GSH (Glutathione) - GPX4 (Glutathione Peroxidase 4) regulatory axis suggests that the role of this axis in inhibiting ferroptosis is weakened. Through intersection screening and validation, we found that Mucin 1,cell surface associated (MUC1) can inhibit ferroptosis and is regulated by the APOM gene. Bioinformatics analysis and screening identified miR-4489 as a mediator between the two. Experimental results using the dual luciferase reporter gene confirmed that has-miR-4489 targets MUC1's 3'-UTR and inhibits its expression. In conclusion, this study provides evidence that the APOM gene induces a down-regulation in the expression of the ferroptosis-inhibiting gene MUC1, mediated by miR-4489, thereby impeding the advancement of liver cancer cells through the facilitation of ferroptosis.
原发性肝癌的发病率和死亡率一直居高不下,因此需要研究相关的诊断标志物和抑制机制,以有效降低其影响。载脂蛋白 M(ApoM)在抑制肿瘤疾病进展方面的重要性逐渐得到认可。然而,其在肝癌发展中的潜在机制仍有待阐明。最近的证据表明,ApoM 与多不饱和脂肪酸(PUFAs)之间可能存在关联,多不饱和脂肪酸(PUFAs)存在的磷脂(PL)过氧化被认为是发生铁死亡的关键因素。这促使我们通过铁死亡途径研究 APOM 基因对肝癌进展的影响,并阐明其潜在机制。本研究发现,APOM 基因过表达的肝癌细胞模型表现出增强的铁死亡效应。此外,观察到 GSH(谷胱甘肽)-GPX4(谷胱甘肽过氧化物酶 4)调节轴的抑制表明该轴在抑制铁死亡中的作用减弱。通过交集筛选和验证,我们发现黏蛋白 1,细胞表面相关(MUC1)可以抑制铁死亡,并受 APOM 基因调控。生物信息学分析和筛选确定 miR-4489 是两者之间的调节介体。使用双荧光素酶报告基因的实验结果证实了 has-miR-4489 靶向 MUC1 的 3'-UTR 并抑制其表达。总之,本研究表明,APOM 基因通过 miR-4489 下调铁死亡抑制基因 MUC1 的表达,从而促进铁死亡,阻碍肝癌细胞的进展。